↓ Skip to main content

New Approaches to Targeting B Cells for Myasthenia Gravis Therapy

Overview of attention for article published in Frontiers in immunology, February 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (75th percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter
2 X users
patent
2 patents

Readers on

mendeley
73 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
New Approaches to Targeting B Cells for Myasthenia Gravis Therapy
Published in
Frontiers in immunology, February 2020
DOI 10.3389/fimmu.2020.00240
Pubmed ID
Authors

Ruksana Huda

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 73 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 73 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 11 15%
Researcher 8 11%
Student > Bachelor 6 8%
Student > Doctoral Student 5 7%
Student > Postgraduate 5 7%
Other 13 18%
Unknown 25 34%
Readers by discipline Count As %
Medicine and Dentistry 17 23%
Immunology and Microbiology 8 11%
Biochemistry, Genetics and Molecular Biology 5 7%
Pharmacology, Toxicology and Pharmaceutical Science 5 7%
Neuroscience 5 7%
Other 8 11%
Unknown 25 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 April 2024.
All research outputs
#4,931,140
of 26,512,053 outputs
Outputs from Frontiers in immunology
#5,546
of 33,463 outputs
Outputs of similar age
#96,074
of 388,924 outputs
Outputs of similar age from Frontiers in immunology
#146
of 665 outputs
Altmetric has tracked 26,512,053 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 33,463 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 388,924 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 665 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.